Apogee Therapeutics (APGE) Earnings Date & Reports

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

APGE is expected to report earnings to fall 33.96% to -69 cents per share on August 17

Apogee Therapeutics APGE Stock Earnings Reports

Q2'26

Est.

$-0.70

Q1'26

Missed

by $0.38

Q4'25

Missed

by $0.41

Q3'25

Missed

by $0.50

Q2'25

Missed

by $0.51

The last earnings report on May 11 showed earnings per share of -105 cents, missing the estimate of -68 cents. With 627.14K shares outstanding, the current market capitalization sits at 10.02B.

View a ticker or compare two or three

Compare

APGE

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for APGE